Effects of a novel perturbation balance training program on laboratory and Real-World Trip-Induced losses of balance and falls among Balance-Impaired older adults

NCT ID NCT07891637

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 23, 2026 · Last updated Oct 23, 2026

Summary

The goal of this clinical trial is to learn if a novel balance training stepping exercise can reduce the risk of falling among adults over the age of 65. The main question it aims to answer is: * Does the novel stepping exercise improve laboratory-based measurements of balance and fall rate? * Does the novel stepping exercise improve real-world measurements of balance and fall rate? Researchers will compare the novel stepping exercise to 1) a more established stepping exercise that requires more expensive equipment, and 2) a more established general exercise program focusing on strength and standing balance without stepping. Participants will: * complete their assigned exercise intervention twice a week for three weeks, then complete booster sessions of their assigned exercise intervention once a month during months 1-5 after completing the initial three weeks of intervention * complete laboratory sessions to test their balance: a) before intervention, b) 1 week after intervention, and c) 6 months after intervention * use a wearable sensor daily for 12 months after intervention to capture any loss of balance or fall events

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Aug 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 65 years * Moderate balance impairment as indicated by best unipedal stance time \<10 seconds * Able to ambulate household distances and tolerate testing and training without an assistive device * No significant cognitive impairment (telephone Montreal Cognitive Assessment \>18) * Functional vision and hearing (with correction if needed) * Comprehension of written and spoken English * Willing and able to study-required voice recorders * Limited physical activity (\<150 min/week moderate-vigorous), not in physical therapy, not presently in balance training programs (such as Tai Chi training). * Not having acute or chronic conditions which would significantly alter study participation and markedly bias the results: active or symptomatic cardiopulmonary conditions; active or unstable metabolic conditions such as labile glycemic control; alcohol intake \>3 oz/day; hemiplegia or lower limb amputation; acute medical conditions, such as acute flare-up of joint condition or infection; significant orthopedic or musculoskeletal condition that does not allow weight bearing. * Osteoporosis screening (only for subjects exposed to lab-induced trip): bone mineral density t-score \> -2.5 and no history of fragility fracture of the hip, spine, or wrist.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Accidental fall are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • Virginia Tech

    Blacksburg, Virginia, 24061, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.